Durability of bioprosthetic valves in the pulmonary position: Long-term follow-up of 181 implants in patients with congenital heart disease Cheul Lee,

Slides:

Advertisements

Similar presentations

Blood lactate level during extracorporeal life support as a surrogate marker for survival Sung Jun Park, MD, Sang-pil Kim, MD, PhD, Joon Bum Kim, MD,

Advertisements

Max B. Mitchell, MD The Journal of Thoracic and Cardiovascular Surgery

Manuel J. Antunes, MD, PhD, DSc

Aortic valve replacement in low-flow, low-gradient aortic stenosis: Left ventricular ejection fraction matters Victor Dayan, MD, PhD, Philippe Pibarot,

Sergey Leontyev, MD, Michael A

Valve-sparing repair to alleviate pulmonary regurgitation may lead to as much right ventricular dilatation as a transannular patch: A catch-22? Tae-Jin.

Outcome of 200 patients after an extracardiac Fontan procedure

When is the Ross operation a good option to treat aortic valve disease? Tirone E. David, MD, Anna Woo, MD, Susan Armstrong, MSc, Manjula Maganti, MSc

Incidence and outcomes of right-sided endocarditis in patients with congenital heart disease after surgical or transcatheter pulmonary valve implantation

Pulmonary atresia with ventricular septal defects and major aortopulmonary collateral arteries: Unifocalization brings no long-term benefits Yves d'Udekem,

Aortic root translocation with atrial switch: Another surgical option for congenitally corrected transposition of the great arteries with isolated pulmonary.

Long-term follow-up after aortic valve replacement with Edwards Prima Plus stentless bioprostheses in patients younger than 60 years of age Torsten Christ,

Ruptured sinus of Valsalva aneurysm: Transaortic repair may cause sinus of Valsalva distortion and aortic regurgitation Sung-Ho Jung, MD, Tae-Jin Yun,

Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer Hong.

Does limited right ventriculotomy prevent right ventricular dilatation and dysfunction in patients who undergo transannular repair of tetralogy of Fallot?

Blood lactate level during extracorporeal life support as a surrogate marker for survival Sung Jun Park, MD, Sang-pil Kim, MD, PhD, Joon Bum Kim, MD,

Pulmonary hypertension in valve disease: A beast of the past?

Intrinsic cardiac stem cells are essential for regeneration

Centers for Disease Control “increased-risk” organ donor: Not so risky? Francis D. Pagani, MD, PhD The Journal of Thoracic and Cardiovascular Surgery

Form ever follows function

William M. DeCampli, MD, PhD

Detachment of the tricuspid valve for ventricular septal defect closure in infants younger than 3 months Ji Hyun Bang, MD, Chun Soo Park, MD, PhD, Jeong-Jun.

Application of a neuroscience research model to study neuroprotection in children with congenital heart disease Nobuyuki Ishibashi, MD, Richard A. Jonas,

It is still mostly about the mitral valve

Go on-pump or off-pump in diabetic patients?

Surgeons, valve repair in severely unbalanced atrioventricular septal defect, and the emperor's new clothes David M. Overman, MD The Journal of Thoracic.

Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement Ole Lund, MD, PhD, Martin Bland,

The lord of the rings Antonio Miceli, MD, PhD

Outcomes of Mechanical Valves in the Pulmonic Position in Patients With Congenital Heart Disease Over a 20-Year Period Hong Ju Shin, MD, Young-Hwue Kim,

Outcome after surgery for prosthetic valve endocarditis and the impact of preoperative treatment Herko Grubitzsch, MD, PhD, Andreas Schaefer, Christoph.

Valve replacement surgery for older individuals with preoperative atrial fibrillation: The effect of prosthetic valve choice and surgical ablation Ho.

Does the degree of preoperative mitral regurgitation predict survival or the need for mitral valve repair or replacement in patients with anomalous origin.

Aditya K. Kaza, MD The Journal of Thoracic and Cardiovascular Surgery

Vladimiro L. Vida, MD, PhD, Fabio Zucchetta, MD, Giovanni Stellin, MD

Transcatheter aortic valve replacement in intermediate-risk patients

Innovation and science: The future of valve design

The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery Vinay Badhwar, MD The Journal of Thoracic and.

Stentless biological valved conduit for aortic root replacement: Initial experience with the Shelhigh BioConduit model NR-2000C Abdullah Kaya, MD, Robin.

Predictors affecting durability of epicardial pacemaker leads in pediatric patients Hiroomi Murayama, MD, Masanobu Maeda, MD, Hajime Sakurai, MD, Akihiko.

Choice of second pericardial drainage tube for posterior placement

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Increased postoperative and respiratory complications in patients with congenital heart disease associated with heterotaxy Matthew Swisher, BS, Richard.

Risk factors for early pulmonary valve replacement after valve disruption in congenital pulmonary stenosis and tetralogy of Fallot Brian Kogon, MD, Courtney.

Commentary: Bioprosthetic aortic valve replacement: A high standard of comparison for transcatheter aortic valve implantation Aaron Martin, MD, Michael.

Intersurgeon variability in long-term outcomes after transatrial repair of tetralogy of Fallot: 25 years' experience with 675 patients Yves d'Udekem,

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Sutureless valve implantation: Every detail counts

Biomaterials for heart valve replacement: Conjectures and refutations

Right ventricular exclusion procedure for right ventricular failure of Ebstein's anomaly Sungkyu Cho, MD, Woong-Han Kim, MD, PhD, Jae Gun Kwak, MD, Chun.

Transpulmonary arterial repair of type 1 ventricular septal defect will induce pulmonary regurgitation: Appraisal of subpulmonic approach Shao-Ju Chien,

Younger age and valve oversizing are predictors of structural valve deterioration after pulmonary valve replacement in patients with tetralogy of Fallot

Surgery for rheumatic tricuspid valve disease: A 30-year experience

The origins of open heart surgery at the University of Minnesota 1951 to 1956 Richard A. DeWall, MD The Journal of Thoracic and Cardiovascular Surgery

Prioritizing quality improvement in pediatric cardiac surgery

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

Tissue valve, nitinol stent, or storage solution

Apparently, size matters…in congenital heart disease and brain injury

Outcomes of Biventricular Repair for Congenitally Corrected Transposition of the Great Arteries Hong-Gook Lim, MD, PhD, Jeong Ryul Lee, MD, PhD, Yong.

The continuing challenge of congenital heart disease in China

Commentary: When a choice is not an echo

Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement Todd M. Dewey,

The Robin Hood principle in the treatment of congenital heart disease: Taking technologic developments intended for adults and using it in kids Paul.

Preoperative PFTs: The answer is blowing in the wind

Early Surgical Correction of Atrioventricular Valvular Regurgitation in Single-Ventricle Patients Jae Gun Kwak, MD, Chun Soo Park, MD, Chang-Ha Lee,

Reversal of protein-losing enteropathy with calcium replacement in a patient after Fontan operation Soo-Jin Kim, MD, In-Seung Park, MD, Jin-Young Song,

Chordal replacement with polytetrafluoroethylene sutures for mitral valve repair: A 25- year experience Tirone E. David, MD, Susan Armstrong, MSc, Joan.

Durability of pericardial versus porcine bioprosthetic heart valves

Which biologic valve should we select for the 45- to 65-year-old age group requiring aortic valve replacement? F. Dagenais, MD, P. Cartier, MD, P. Voisine,

The significance of pulmonary annulus size in the surgical management of transposition of the great arteries with ventricular septal defect and pulmonary.

Presentation transcript:

Durability of bioprosthetic valves in the pulmonary position: Long-term follow-up of 181 implants in patients with congenital heart disease Cheul Lee, MD, PhD, Chun Soo Park, MD, Chang-Ha Lee, MD, Jae Gun Kwak, MD, Soo-Jin Kim, MD, Woo-Sup Shim, MD, Jin Young Song, MD, Eun Young Choi, MD, Sang Yun Lee, MD The Journal of Thoracic and Cardiovascular Surgery Volume 142, Issue 2, Pages 351-358 (August 2011) DOI: 10.1016/j.jtcvs.2010.12.020 Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 A, Distribution of patient ages at the time of pulmonary valve replacement. B, Distribution of bioprosthetic valve sizes used. The Journal of Thoracic and Cardiovascular Surgery 2011 142, 351-358DOI: (10.1016/j.jtcvs.2010.12.020) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 A, Overall freedom from reoperation. B, Overall freedom from both prosthetic valve failure and dysfunction. Numbers above the x-axis represent patients remaining at risk. The Journal of Thoracic and Cardiovascular Surgery 2011 142, 351-358DOI: (10.1016/j.jtcvs.2010.12.020) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Valve type-stratified Kaplan–Meier curves. A, Freedom from reoperation. B, Freedom from both prosthetic valve failure and dysfunction. Numbers below the graph represent patients remaining at risk. SP, Stented porcine valve; SB, stented bovine pericardial valve; SL, stentless valve. The Journal of Thoracic and Cardiovascular Surgery 2011 142, 351-358DOI: (10.1016/j.jtcvs.2010.12.020) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

Figure 4 Diagnosis-stratified Kaplan–Meier curves. A, Freedom from reoperation. B, Freedom from both prosthetic valve failure and dysfunction. Numbers below the graph represent patients remaining at risk. TOF, Tetralogy of Fallot; PA, pulmonary atresia; VSD, ventricular septal defect. The Journal of Thoracic and Cardiovascular Surgery 2011 142, 351-358DOI: (10.1016/j.jtcvs.2010.12.020) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

Figure 5 Age-stratified Kaplan–Meier curves. A, Freedom from reoperation. B, Freedom from both prosthetic valve failure and dysfunction. Numbers below the graph represent patients remaining at risk. The Journal of Thoracic and Cardiovascular Surgery 2011 142, 351-358DOI: (10.1016/j.jtcvs.2010.12.020) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions